中国肺癌杂志2025，Vol.28Issue(10)：798-806,9.DOI:10.3779/j.issn.1009-3419.2025.106.28
TNMB分期在肺癌中的研究进展
Research Progress of TNMB Staging in Lung Cancer
Yuanyuan ZHAN 1Yue LI 1Cheng SHEN1
作者信息
- 1. @@@1West China School of Medicine||2Department of Thoracic Surgery,West China Hospital,Sichuan University,Chengdu 610041,China
- 折叠
摘要
Abstract
Lung cancer is the malignant tumor with the highest incidence and mortality in China,and accurate clinical staging is crucial for judging its prognosis and formulating treatment strategies.Currently,the internationally recog-nized tumor-nodule-metastasis(TNM)staging system centers on tumor anatomical characteristics but struggles to reflect the biological essence of tumors.Based on the TNM staging,the TNM-blood(TNMB)staging incorporates blood molecular biomarkers to achieve multi-dimensional assessment of anatomical and biological characteristics.Initially applied to cutane-ous T-cell lymphoma,it has gradually expanded to the field of lung cancer in recent years.This review summarizes the existing research and applications of TNMB staging in lung cancer,comparatively analyzes the differences between TNMB and the tra-ditional TNM staging in terms of staging basis,evaluation dimensions and clinical efficacy,and further summarizes the existing types of molecular biomarkers related to B staging as well as those expected to be included in B staging.关键词
TNMB分期/TNM分期/肺肿瘤/分子标志物Key words
TNMB staging/TNM staging/Lung neoplasms/Molecular markers引用本文复制引用
Yuanyuan ZHAN,Yue LI,Cheng SHEN..TNMB分期在肺癌中的研究进展[J].中国肺癌杂志,2025,28(10):798-806,9.
